1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque PsoriasisChildren and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque PsoriasisNot yet recruitingPhase 32025-02-18NCT06833307